These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 808639

  • 1. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia.
    Warner MR, Warner RL.
    J Natl Cancer Inst; 1975 Aug; 55(2):289-98. PubMed ID: 808639
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice.
    Jones LA, Bern HA.
    Cancer Res; 1977 Jan; 37(1):67-75. PubMed ID: 830422
    [Abstract] [Full Text] [Related]

  • 3. Effects of age at carcinogen administration and exposure as neonates to 17beta-estradiol on subsequent gland-pair distribution of murine mammary dysplasias.
    Warner MR, Warner RL.
    J Natl Cancer Inst; 1975 Jun; 54(6):1369-72. PubMed ID: 805840
    [Abstract] [Full Text] [Related]

  • 4. Serial transplantation of chemical carcinogen-induced mouse mammary ductal dysplasias.
    Medina D.
    J Natl Cancer Inst; 1979 Feb; 62(2):397-405. PubMed ID: 105203
    [Abstract] [Full Text] [Related]

  • 5. Recovery of transformed nodule and ductal mammary cells from carcinogen-treated C57BL mice.
    Guzman RC, Osborn RC, DeOme KB.
    Cancer Res; 1981 May; 41(5):1808-11. PubMed ID: 6783300
    [Abstract] [Full Text] [Related]

  • 6. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice.
    Medina D.
    J Natl Cancer Inst; 1976 Nov; 57(5):1185-9. PubMed ID: 187796
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY, Kimler BF, Fabian CJ, Petroff BK.
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [Abstract] [Full Text] [Related]

  • 8. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice.
    Ethier SP, Ullrich RL.
    Cancer Res; 1982 May; 42(5):1753-60. PubMed ID: 6802483
    [Abstract] [Full Text] [Related]

  • 9. Morphological and histological characteristics of mammary dysplasias occurring in cell dissociation-derived murine mammary outgrowths.
    Ethier SP, Adams LM, Ullrich RL.
    Cancer Res; 1984 Oct; 44(10):4517-22. PubMed ID: 6205749
    [Abstract] [Full Text] [Related]

  • 10. Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice.
    Medina D.
    J Natl Cancer Inst; 1974 Jul; 53(1):213-21. PubMed ID: 4835107
    [No Abstract] [Full Text] [Related]

  • 11. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
    Telang NT, Kurihara H, Wong GY, Bradlow HL, Osborne MP.
    Anticancer Res; 1991 Jul; 11(3):1021-7. PubMed ID: 1909512
    [Abstract] [Full Text] [Related]

  • 12. Factors influencing expression of mammary ductal dysplasia in cell dissociation-derived murine mammary outgrowths.
    Ethier SP, Ullrich RL.
    Cancer Res; 1984 Oct; 44(10):4523-7. PubMed ID: 6432315
    [Abstract] [Full Text] [Related]

  • 13. Neonatal experiences differentially influence mammary gland morphology, estrogen receptor {α} protein levels, and carcinogenesis in BALB/c mice.
    Boyd AL, Salleh A, Humber B, Yee J, Tomes L, Kerr LR.
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1398-408. PubMed ID: 21084260
    [Abstract] [Full Text] [Related]

  • 14. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D.
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract] [Full Text] [Related]

  • 15. Proliferation of ductal outgrowths by carcinogen-induced rat mammary tumors in gland-free mammary fat pads.
    Rivera EM, Vijayaraghavan S.
    J Natl Cancer Inst; 1982 Aug; 69(2):517-25. PubMed ID: 6810006
    [Abstract] [Full Text] [Related]

  • 16. Enhancement by pituitary isografts of mammary hyperplastic nodules in adreno-ovariectomized mice.
    Yanai R, Nagasawa H.
    J Natl Cancer Inst; 1971 Jun; 46(6):1251-5. PubMed ID: 5088047
    [No Abstract] [Full Text] [Related]

  • 17. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
    Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, Murthy S, Thor AD.
    Cancer Res; 2003 May 15; 63(10):2425-33. PubMed ID: 12750262
    [Abstract] [Full Text] [Related]

  • 18. Prenatal exposure to diethylstilbestrol: ovarian-independent growth of mammary tumors induced by 7,12-dimethylbenz[a]anthracene.
    Boylan ES, Calhoon RE.
    J Natl Cancer Inst; 1981 Apr 15; 66(4):649-52. PubMed ID: 6785506
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review.
    Mori T, Nagasawa H, Bern HA.
    J Environ Pathol Toxicol; 1979 Dec 15; 3(1-2):191-205. PubMed ID: 397957
    [Abstract] [Full Text] [Related]

  • 20. Effects of neonatally-administered 17beta-estradiol on induction of mammary carcinomas by 7, 12-dimethylbenz[a]anthracene in female rats.
    Funato M, Kawaguchi H, Hori T, Yoshikawa T, Gejima K, Kawashima H, Taguchi S, Ninomiya K, Umekita Y, Nagata R, Yoshida H.
    In Vivo; 2006 Dec 15; 20(1):33-7. PubMed ID: 16433025
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.